GRRMF
Price
$50.46
Change
-$23.34 (-31.63%)
Updated
Jun 17 closing price
Capitalization
4.1B
GTHP
Price
$0.23
Change
-$0.00 (-0.00%)
Updated
Jun 17 closing price
Capitalization
7.4M
Interact to see
Advertisement

GRRMF vs GTHP

Header iconGRRMF vs GTHP Comparison
Open Charts GRRMF vs GTHPBanner chart's image
Gerresheimer AG
Price$50.46
Change-$23.34 (-31.63%)
Volume$200
Capitalization4.1B
Guided Therapeutics
Price$0.23
Change-$0.00 (-0.00%)
Volume$7.18K
Capitalization7.4M
GRRMF vs GTHP Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GRRMF vs. GTHP commentary
Jun 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRRMF is a Hold and GTHP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 19, 2025
Stock price -- (GRRMF: $50.46 vs. GTHP: $0.23)
Brand notoriety: GRRMF and GTHP are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GRRMF: 61% vs. GTHP: 46%
Market capitalization -- GRRMF: $4.1B vs. GTHP: $7.4M
GRRMF [@Medical Specialties] is valued at $4.1B. GTHP’s [@Medical Specialties] market capitalization is $7.4M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRRMF’s FA Score shows that 0 FA rating(s) are green whileGTHP’s FA Score has 0 green FA rating(s).

  • GRRMF’s FA Score: 0 green, 5 red.
  • GTHP’s FA Score: 0 green, 5 red.
According to our system of comparison, GTHP is a better buy in the long-term than GRRMF.

Price Growth

GRRMF (@Medical Specialties) experienced а -31.63% price change this week, while GTHP (@Medical Specialties) price change was +31.43% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.96%. For the same industry, the average monthly price growth was -0.64%, and the average quarterly price growth was +1.36%.

Reported Earning Dates

GTHP is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Medical Specialties (-2.96% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
GRRMF($4.1B) has a higher market cap than GTHP($7.4M). GRRMF has higher P/E ratio than GTHP: GRRMF (32.47) vs GTHP (8.86). GTHP YTD gains are higher at: 53.333 vs. GRRMF (-27.656). GRRMF has higher annual earnings (EBITDA): 377M vs. GTHP (-4.08M). GRRMF has more cash in the bank: 133M vs. GTHP (1.84M). GTHP has less debt than GRRMF: GTHP (2.11M) vs GRRMF (1.11B). GRRMF has higher revenues than GTHP: GRRMF (1.96B) vs GTHP (30K).
GRRMFGTHPGRRMF / GTHP
Capitalization4.1B7.4M55,441%
EBITDA377M-4.08M-9,240%
Gain YTD-27.65653.333-52%
P/E Ratio32.478.86367%
Revenue1.96B30K6,530,000%
Total Cash133M1.84M7,240%
Total Debt1.11B2.11M52,534%
FUNDAMENTALS RATINGS
GRRMF vs GTHP: Fundamental Ratings
GRRMF
GTHP
OUTLOOK RATING
1..100
3434
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
82100
PRICE GROWTH RATING
1..100
6234
P/E GROWTH RATING
1..100
8675
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRRMF's Valuation (56) in the null industry is in the same range as GTHP (83). This means that GRRMF’s stock grew similarly to GTHP’s over the last 12 months.

GRRMF's Profit vs Risk Rating (100) in the null industry is in the same range as GTHP (100). This means that GRRMF’s stock grew similarly to GTHP’s over the last 12 months.

GRRMF's SMR Rating (82) in the null industry is in the same range as GTHP (100). This means that GRRMF’s stock grew similarly to GTHP’s over the last 12 months.

GTHP's Price Growth Rating (34) in the null industry is in the same range as GRRMF (62). This means that GTHP’s stock grew similarly to GRRMF’s over the last 12 months.

GTHP's P/E Growth Rating (75) in the null industry is in the same range as GRRMF (86). This means that GTHP’s stock grew similarly to GRRMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIQIX30.33N/A
N/A
Touchstone Non-US Equity Y
GLNKX22.97N/A
N/A
MFS Global New Discovery R2
FTXAX42.68N/A
N/A
FullerThaler Behavioral Sm-Cp Gr A
LINSX21.23N/A
N/A
Lord Abbett International Opp R4
JABNX47.52-0.15
-0.31%
Janus Henderson Balanced N

GRRMF and

Correlation & Price change

A.I.dvisor tells us that GRRMF and SAFLF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRRMF and SAFLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRRMF
1D Price
Change %
GRRMF100%
-31.63%
SAFLF - GRRMF
21%
Poorly correlated
N/A
GTHP - GRRMF
6%
Poorly correlated
N/A
GNGBY - GRRMF
4%
Poorly correlated
-2.86%
ICCM - GRRMF
3%
Poorly correlated
+0.02%
FZMD - GRRMF
1%
Poorly correlated
N/A
More

GTHP and

Correlation & Price change

A.I.dvisor tells us that GTHP and FSPKF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GTHP and FSPKF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTHP
1D Price
Change %
GTHP100%
N/A
FSPKF - GTHP
22%
Poorly correlated
N/A
GRRMF - GTHP
6%
Poorly correlated
-31.63%
GNGBY - GTHP
5%
Poorly correlated
-2.86%
FZMD - GTHP
3%
Poorly correlated
N/A
HOCPY - GTHP
1%
Poorly correlated
-0.76%
More